>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

FDA Reports the Propofol Shortage is Resolved

Tuesday, June 11, 2013

The Food and Drug Administration (FDA) has officially moved propofol injections from the list of drugs currently in shortage to the list of resolved drug shortages.  While the FDA has indicated that propofol is currently available, it may take time for facilities to secure product as it moves through the supply chain.  

If you are not able to access adequate quantities of propofol, please contact the FDA at drugshortages@fda.hhs.gov and Lisa Pearlstein, ASA Pain Medicine and Regulatory Lobbyist, at l.pearlstein@asawash.org

Learn more about ASA's leadership in combating drug shortages.

« Back to Washington Alerts